Zahra Masoud

4CMedB, a new multi-antigen vaccine designed to control group B meningococcal disease, had no effect on carriage of disease-causing meningococci in adolescents.

Results of this study showed that patients with CSF leak associated bacterial meningitis have a relatively high recurrence rate, despite attempts to repair the leak or vaccination.